Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP833452.RAI6R1Qn0A0B2SBI-4MlkFL1pgxFTzrluKfNyLoBzF2Eg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP833452.RAI6R1Qn0A0B2SBI-4MlkFL1pgxFTzrluKfNyLoBzF2Eg130_assertion type Assertion NP833452.RAI6R1Qn0A0B2SBI-4MlkFL1pgxFTzrluKfNyLoBzF2Eg130_head.
- NP833452.RAI6R1Qn0A0B2SBI-4MlkFL1pgxFTzrluKfNyLoBzF2Eg130_assertion description "[To investigate whether human angiotensinogen protects against tumor progression in vivo, we established an original bitransgenic model in which transgenic mice expressing human angiotensinogen (Hu-AGT-TG mice) were crossed with a transgenic mouse model of hepatocellular carcinoma (HCC-TG mice).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP833452.RAI6R1Qn0A0B2SBI-4MlkFL1pgxFTzrluKfNyLoBzF2Eg130_provenance.
- NP833452.RAI6R1Qn0A0B2SBI-4MlkFL1pgxFTzrluKfNyLoBzF2Eg130_assertion evidence source_evidence_literature NP833452.RAI6R1Qn0A0B2SBI-4MlkFL1pgxFTzrluKfNyLoBzF2Eg130_provenance.
- NP833452.RAI6R1Qn0A0B2SBI-4MlkFL1pgxFTzrluKfNyLoBzF2Eg130_assertion SIO_000772 19318581 NP833452.RAI6R1Qn0A0B2SBI-4MlkFL1pgxFTzrluKfNyLoBzF2Eg130_provenance.
- NP833452.RAI6R1Qn0A0B2SBI-4MlkFL1pgxFTzrluKfNyLoBzF2Eg130_assertion wasDerivedFrom befree-20140225 NP833452.RAI6R1Qn0A0B2SBI-4MlkFL1pgxFTzrluKfNyLoBzF2Eg130_provenance.
- NP833452.RAI6R1Qn0A0B2SBI-4MlkFL1pgxFTzrluKfNyLoBzF2Eg130_assertion wasGeneratedBy ECO_0000203 NP833452.RAI6R1Qn0A0B2SBI-4MlkFL1pgxFTzrluKfNyLoBzF2Eg130_provenance.